share_log

アステラス製薬:米国食品医薬品局、アステラス製薬がゾルベツキシマブの生物製剤ライセンス申請を再提出したことを認め、新しい措置日を設定

Astellas Pharma: US Food and Drug Administration acknowledges that Astellas Pharma has re-submitted a biologics license application for zolbetuximab and sets a new date for action

JPX ·  May 30 22:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more